Our findings highlight several key genes, such as HLA-B, HLA-C, NRP1, and MUC2, and pathways, such as neurotransmitter regulation and lipid metabolism, which are implicated in the development and progression of MI and SMDs. Here, MUC2 is linked to spondylometaphyseal dysplasia, Sedaghatian type.